The Hippo signaling pathway that helps control tissue size in animals and malfunctions in cancers already existed before ...

Inside every cell, a finely tuned metabolic network determines when to build, recycle, or stop producing essential molecules.

Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...

Steatotic liver disease (SLD), mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), ...